Page last updated: 2024-10-23

astemizole and Hypokalemia

astemizole has been researched along with Hypokalemia in 1 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goss, JE1
Ramo, BW1
Blake, K1

Other Studies

1 other study available for astemizole and Hypokalemia

ArticleYear
Torsades de pointes associated with astemizole (Hismanal) therapy.
    Archives of internal medicine, 1993, Dec-13, Volume: 153, Issue:23

    Topics: Aged; Aged, 80 and over; Astemizole; Erythromycin; Female; Humans; Hypokalemia; Torsades de Pointes

1993